![](/_next/image?url=%2Fwp-content%2Fuploads%2F2024%2F07%2FWebinar-1_Preview-news-sito.png&w=3840&q=85)
Webinar
Webinar: Rapid single cell functional characterization for cell therapy potency
12 July 2024
MONACO, PRINCIPALITY OF MONACO, NEW YORK, NY, and BOLOGNA, ITALY, March 1, 2018:
Lyfebulb, a patient empowerment platform that connects patients, industry and investors to support user-driven innovation in chronic diseases, and Helsinn, with activities focused on early-stage investments in areas of high unmet patient need, have announced today that Cellply has been selected as one the eleven finalist companies for the Lyfebulb-Helsinn Innovation Summit & Award in Oncology. The Lyfebulb-Helsinn Innovation Summit & Award final event will be hosted on 26-27 March 2018, by Lyfebulb and Helsinn at the Monte-Carlo Bay Hotel and Resort, in Monaco, Principality of Monaco.
Read the full story here